Pfizer bets big on ADCs with $43-billion Seagen acquisition
Pfizer bets big on ADCs with $43-billion Seagen acquisition
About this item
Full title
Pfizer bets big on ADCs with $43-billion Seagen acquisition
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Nature reviews. Drug discovery, 2023-05, Vol.22 (5), p.342-342
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Alternative Titles
Full title
Pfizer bets big on ADCs with $43-billion Seagen acquisition
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2800146863
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2800146863
Other Identifiers
ISSN
1474-1776
E-ISSN
1474-1784
DOI
10.1038/d41573-023-00060-6
